يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"Penman SL"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المؤلفون: Miller G; Department of Pharmacology Toxicology, University at Buffalo, State University of New York, NY, United States., Pareek O; Department of Pharmacology Toxicology, University at Buffalo, State University of New York, NY, United States., Penman SL; Department of Pharmacology Toxicology, University at Buffalo, State University of New York, NY, United States., Thanos PK; Department of Pharmacology Toxicology, University at Buffalo, State University of New York, NY, United States.

    المصدر: Current pharmaceutical design [Curr Pharm Des] 2024 Jun 07. Date of Electronic Publication: 2024 Jun 07.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9602487 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4286 (Electronic) Linking ISSN: 13816128 NLM ISO Abbreviation: Curr Pharm Des Subsets: MEDLINE

  3. 3
    دورية أكاديمية

    المؤلفون: Pieren M; BioVersys AG, Basel, Switzerland., Abáigar Gutiérrez-Solana A; CTI Laboratory Services S.L., Ibaizabal bidea, 702, 48160 Derio, Biscay, Spain., Antonijoan Arbós RM; Institut de Recerca de l'HSCSP, IIB Sant Pau, Centre d'Investigació de Medicaments (CIM), Barcelona, Spain., Boyle GW; GSK, Stevenage, UK., Davila M; BioVersys AG, Basel, Switzerland., Davy M; GSK, Stevenage, UK., Gitzinger M; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France., Husband L; BioVersys SAS, Lille, France., Martínez-Martínez MS; GSK, Tres Cantos, Spain., Mazarro DO; Clinical Trials Unit, Clinical Pharmacology Department, Facultad de Medicina, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain., Pefani E; GSK, Stevenage, UK., Penman SL; GSK, London, UK., Remuiñán MJ; GSK, Tres Cantos, Spain., Vlasakakis G; GSK, Philadelphia, PA, USA., Zeitlinger M; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Vienna, Austria., Dale GE; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France.

    المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jun 03; Vol. 79 (6), pp. 1353-1361.

    نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

  4. 4
    دورية أكاديمية

    المؤلفون: Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Mihalkovic A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Novalen M; Center for Addiction and Mental Health and Departments of Pharmacology and Toxicology, and Psychiatry, University of Toronto, Toronto, Ontario, Canada., Hammond N; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Eiden R; Department of Psychology, Social Science Research Institute, Pennsylvania State University, University Park, PA, USA., Khokhar JY; Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Tyndale RF; Center for Addiction and Mental Health and Departments of Pharmacology and Toxicology, and Psychiatry, University of Toronto, Toronto, Ontario, Canada., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA.

    المصدر: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco [Nicotine Tob Res] 2024 May 22; Vol. 26 (6), pp. 724-732.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815751 Publication Model: Print Cited Medium: Internet ISSN: 1469-994X (Electronic) Linking ISSN: 14622203 NLM ISO Abbreviation: Nicotine Tob Res Subsets: MEDLINE

  5. 5
    دورية أكاديمية

    المؤلفون: Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Wang J; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Pareek O; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Freeman-Striegel L; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Mohr P; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Khan A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA., Eiden RD; Department of Psychology, Social Science Research Institute, The Pennsylvania State University, University Park, PA, 16801, USA., Chakraborty S; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, NY, 14203-1016, USA. thanos@buffalo.edu.; Department of Psychology, University at Buffalo, Buffalo, NY, USA. thanos@buffalo.edu.

    المصدر: Psychopharmacology [Psychopharmacology (Berl)] 2024 May 11. Date of Electronic Publication: 2024 May 11.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

  6. 6
    دورية أكاديمية

    المؤلفون: Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Wang J; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Freeman-Striegel L; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Krayevsky A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Eiden RD; Department of Psychology and Social Science Research Institute, The Pennsylvania State University, University Park, PA, USA., Chakraborty S; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Psychology, University at Buffalo, Buffalo, NY, USA. Electronic address: thanos@buffalo.edu.

    المصدر: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2024 Sep; Vol. 242, pp. 173808. Date of Electronic Publication: 2024 Jun 22.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0367050 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5177 (Electronic) Linking ISSN: 00913057 NLM ISO Abbreviation: Pharmacol Biochem Behav Subsets: MEDLINE

  7. 7
    دورية أكاديمية

    المؤلفون: Diacon AH; TASK, Cape Town, South Africa., Barry CE 3rd; National Institutes of Health, Bethesda, MD, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Carlton A; GSK, London, UK., Chen RY; National Institutes of Health, Bethesda, MD, USA., Davies M; GSK, London, UK., de Jager V; TASK, Cape Town, South Africa., Fletcher K; GSK, London, UK., Koh GCKW; GSK, London, UK.; Generate:Biomedicines, Boston, MA, USA., Kontsevaya I; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.; German Center for Infection Research, Borstel, Germany.; Respiratory Medicine and Infectious Diseases, University of Lübeck, Lübeck, Germany.; Research Center Borstel, Leibniz Lung Center, German Center for Infection Research, Borstel and the University of Lübeck, Lübeck, Germany.; Imperial College London, London, UK., Heyckendorf J; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany., Lange C; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.; German Center for Infection Research, Borstel, Germany.; Respiratory Medicine and Infectious Diseases, University of Lübeck, Lübeck, Germany.; Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA., Reimann M; Research Center Borstel, Leibniz Lung Center, Borstel, Germany.; German Center for Infection Research, Borstel, Germany.; Respiratory Medicine and Infectious Diseases, University of Lübeck, Lübeck, Germany., Penman SL; GSK, London, UK., Scott R; GSK, London, UK., Maher-Edwards G; GSK, London, UK., Tiberi S; GSK, London, UK.; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Vlasakakis G; GSK, Philadelphia, PA, USA., Upton CM; TASK, Cape Town, South Africa., Aguirre DB; GSK, Tres Cantos, Spain. david.a.barros@gsk.com.

    المصدر: Nature medicine [Nat Med] 2024 Mar; Vol. 30 (3), pp. 896-904. Date of Electronic Publication: 2024 Feb 16.

    نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

    بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

  8. 8
    دورية أكاديمية

    المؤلفون: Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Psychology, University at Buffalo, Buffalo, NY, USA., Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Wang J; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA; Department of Biostatistics, University at Buffalo, Buffalo, NY, USA., Freeman-Striegel L; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Khan A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Pareek O; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Weiss M; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Mohr P; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Eiden RD; Department of Psychology and Social Science Research Institute, The Pennsylvania State University, University Park, PA 16801, USA., Chakraborty S; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA; Department of Biostatistics, University at Buffalo, Buffalo, NY, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Psychology, University at Buffalo, Buffalo, NY, USA. Electronic address: thanos@buffalo.edu.

    المصدر: Life sciences [Life Sci] 2024 Mar 01; Vol. 340, pp. 122447. Date of Electronic Publication: 2024 Jan 20.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE

  9. 9
    دورية أكاديمية

    المؤلفون: Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., Roeder NM; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., Berthold EC; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Senetra AS; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Marion M; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., Richardson BJ; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., White O; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., Fearby NL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., McCurdy CR; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA; Translational Drug Development Core, Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA; Department of Medicinal Chemistry, University of Florida, Gainesville, FL, USA., Hamilton J; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA., Sharma A; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA; Translational Drug Development Core, Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA. Electronic address: thanos@buffalo.edu.

    المصدر: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2023 Oct; Vol. 231, pp. 173633. Date of Electronic Publication: 2023 Sep 15.

    نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0367050 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5177 (Electronic) Linking ISSN: 00913057 NLM ISO Abbreviation: Pharmacol Biochem Behav Subsets: MEDLINE

  10. 10
    دورية أكاديمية

    المؤلفون: Penman SL; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Berthold EC; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Mihalkovic A; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., Hammond N; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA., McCurdy CR; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Translational Drug Development Core, Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA.; Department of Medicinal Chemistry, University of Florida, Gainesville, FL, USA., Blum K; Division of Addiction Research & Education, Center for Mental Health & Sports, Exercise and Global Mental Health, Western University Health Sciences, Pomona, CA 91766, USA.; Department of Psychiatry, School of Medicine, University of Vermont, Burlington, VT 05405, USA., Eiden RD; Department of Psychology, Pennsylvania State University, State College, PA, USA., Sharma A; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Translational Drug Development Core, Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA., Thanos PK; Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Department of Psychology, University at Buffalo, Buffalo, NY, USA.

    المصدر: Current pharmaceutical design [Curr Pharm Des] 2023; Vol. 29 (27), pp. 2149-2160.

    نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

    بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9602487 Publication Model: Print Cited Medium: Internet ISSN: 1873-4286 (Electronic) Linking ISSN: 13816128 NLM ISO Abbreviation: Curr Pharm Des Subsets: MEDLINE